These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36109339)
1. Organogold(III) Complexes Display Conditional Photoactivities: Evolving From Photodynamic into Photoactivated Chemotherapy in Response to O Luo Y; Cao B; Zhong M; Liu M; Xiong X; Zou T Angew Chem Int Ed Engl; 2022 Nov; 61(45):e202212689. PubMed ID: 36109339 [TBL] [Abstract][Full Text] [Related]
4. Vacancy Engineering to Regulate Photocatalytic Activity of Polymer Photosensitizers for Amplifying Photodynamic Therapy against Hypoxic Tumors. Bai J; Peng C; Lv W; Liu J; Hei Y; Bo X ACS Appl Mater Interfaces; 2021 Aug; 13(33):39055-39065. PubMed ID: 34433248 [TBL] [Abstract][Full Text] [Related]
5. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation. Zhang C; Guo X; Da X; Wang Z; Wang X; Zhou Q Dalton Trans; 2021 Aug; 50(31):10845-10852. PubMed ID: 34296720 [TBL] [Abstract][Full Text] [Related]
6. Colloidal plasmonic gold nanoparticles and gold nanorings: shape-dependent generation of singlet oxygen and their performance in enhanced photodynamic cancer therapy. Yang Y; Hu Y; Du H; Ren L; Wang H Int J Nanomedicine; 2018; 13():2065-2078. PubMed ID: 29670350 [TBL] [Abstract][Full Text] [Related]
7. Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments. Shaili E Sci Prog; 2014; 97(Pt 1):20-40. PubMed ID: 24800467 [TBL] [Abstract][Full Text] [Related]
8. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy. Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapy. Zheng Y; Li Z; Chen H; Gao Y Eur J Pharm Sci; 2020 Mar; 144():105213. PubMed ID: 31926941 [TBL] [Abstract][Full Text] [Related]
10. Development of Wireless Power-Transmission-Based Photodynamic Therapy for the Induction of Cell Death in Cancer Cells by Cyclometalated Iridium(III) Complexes. Yokoi K; Yasuda Y; Kanbe A; Imura T; Aoki S Molecules; 2023 Feb; 28(3):. PubMed ID: 36771099 [TBL] [Abstract][Full Text] [Related]
11. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives. Lee SY; Kim CY; Nam TG Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303 [TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy. Huang H; Banerjee S; Sadler PJ Chembiochem; 2018 Aug; 19(15):1574-1589. PubMed ID: 30019476 [TBL] [Abstract][Full Text] [Related]
13. Exposing "Bright" Metals: Promising Advances in Photoactivated Anticancer Transition Metal Complexes. Bjelosevic A; Pages BJ; Spare LK; Deo KM; Ang DL; Aldrich-Wright JR Curr Med Chem; 2018 Feb; 25(4):478-492. PubMed ID: 28554317 [TBL] [Abstract][Full Text] [Related]
14. Conquering the Hypoxia Limitation for Photodynamic Therapy. Wan Y; Fu LH; Li C; Lin J; Huang P Adv Mater; 2021 Dec; 33(48):e2103978. PubMed ID: 34580926 [TBL] [Abstract][Full Text] [Related]
15. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy. Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916 [TBL] [Abstract][Full Text] [Related]
16. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA. Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424 [TBL] [Abstract][Full Text] [Related]